NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
March 15, 2005 • Volume 2 / Number 11 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Cancer Center Web Sites: Another Way to Locate Clinical Trials

Patients and clinicians who are searching for clinical trials can use several resources, including NCI's PDQ database (http://cancer.gov/clinicaltrials/search) and Cancer Information Service (1-800-4-CANCER), as well as the NIH's ClinicalTrials.gov database (http://www.clinicaltrials.gov), which is managed by the National Library of Medicine.

Another way to search for clinical trials - one that may be more practical, in some cases - is by searching the NCI-designated Cancer Centers' Web sites directly.

More about locating clinical trials at NCI-designated Cancer Centers can be found at: http://cancer.gov/clinicaltrials/finding/NCI-cancer-centers/map. Patients or family members should note that the summaries describing these opportunities may be written in technical language and should be shared with a health care provider before making a decision about enrollment in a trial.

Bevacizumab Prolongs Survival for Some Patients
with Advanced Lung Cancer
Preliminary results from a large, randomized, NCI-sponsored clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those who received bevacizumab (Avastin) with standard chemotherapy lived longer (median survival 12.5 months) than patients who received the same chemotherapy without bevacizumab (median survival 10.2 months). This difference is statistically significant. More information can be found at http://cancer.gov/newscenter/pressreleases/AvastinLung.
 
Cancer Center Web Sites: Another Way to Locate Clinical Trials

Patients and clinicians who are searching for clinical trials can use several resources, including NCI's PDQ database (http://cancer.gov/clinicaltrials/search) and Cancer Information Service (1-800-4-CANCER), as well as the NIH's ClinicalTrials.gov database (http://www.clinicaltrials.gov), which is managed by the National Library of Medicine.

Another way to search for clinical trials - one that may be more practical, in some cases - is by searching the NCI-designated Cancer Centers' Web sites directly.

More about locating clinical trials at NCI-designated Cancer Centers can be found at: http://cancer.gov/clinicaltrials/finding/NCI-cancer-centers/map. Patients or family members should note that the summaries describing these opportunities may be written in technical language and should be shared with a health care provider before making a decision about enrollment in a trial.

Bevacizumab Prolongs Survival for Some Patients
with Advanced Lung Cancer
Preliminary results from a large, randomized, NCI-sponsored clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those who received bevacizumab (Avastin) with standard chemotherapy lived longer (median survival 12.5 months) than patients who received the same chemotherapy without bevacizumab (median survival 10.2 months). This difference is statistically significant. More information can be found at http://cancer.gov/newscenter/pressreleases/AvastinLung.